Gsa Capital Partners LLP Viatris Inc Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$11.27 - $13.53 $449,436 - $539,562	39,879 New	39,879 $476,000
Q3 2023 Nov 15, 2023	BUY	$9.59 - $11.35 $1.68 Million - $1.99 Million	175,035 New	175,035 $1.73 Million
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $278,980 - $371,772	30,324 New	30,324 $291,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $1.12 Million - $1.48 Million	132,531 New	132,531 $1.13 Million
Q2 2022 Aug 09, 2022	SELL	$9.95 - $12.27 $469,809 - $579,352	-47,217 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $463,198 - $727,141	47,217 New	47,217 $514,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.